191 related articles for article (PubMed ID: 9389531)
1. The role of the active site cysteine in catalysis by type 1 iodothyronine deiodinase.
Sun BC; Harney JW; Berry MJ; Larsen PR
Endocrinology; 1997 Dec; 138(12):5452-8. PubMed ID: 9389531
[TBL] [Abstract][Full Text] [Related]
2. Iodothyronine deiodinase activities in FRTL5 cells: predominance of type I 5'-deiodinase.
Borges M; Ingbar SH; Silva JE
Endocrinology; 1990 Jun; 126(6):3059-68. PubMed ID: 2351108
[TBL] [Abstract][Full Text] [Related]
3. Deiodination of thyroid hormone by human liver.
Visser TJ; Kaptein E; Terpstra OT; Krenning EP
J Clin Endocrinol Metab; 1988 Jul; 67(1):17-24. PubMed ID: 3379132
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for thyroid hormone deiodination by mammalian type I iodothyronine deiodinases.
Toyoda N; Kaptein E; Berry MJ; Harney JW; Larsen PR; Visser TJ
Endocrinology; 1997 Jan; 138(1):213-9. PubMed ID: 8977406
[TBL] [Abstract][Full Text] [Related]
5. Substitution of cysteine for a conserved alanine residue in the catalytic center of type II iodothyronine deiodinase alters interaction with reducing cofactor.
Kuiper GG; Klootwijk W; Visser TJ
Endocrinology; 2002 Apr; 143(4):1190-8. PubMed ID: 11897672
[TBL] [Abstract][Full Text] [Related]
6. Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase.
Mol JA; Visser TJ
Endocrinology; 1985 Jul; 117(1):8-12. PubMed ID: 4006868
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for the substrate selectivity of cat type I iodothyronine deiodinase.
Kuiper GG; Wassen F; Klootwijk W; Van Toor H; Kaptein E; Visser TJ
Endocrinology; 2003 Dec; 144(12):5411-21. PubMed ID: 12960017
[TBL] [Abstract][Full Text] [Related]
8. Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism.
Visser TJ; Kaplan MM; Leonard JL; Larsen PR
J Clin Invest; 1983 Apr; 71(4):992-1002. PubMed ID: 6833498
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a propylthiouracil-insensitive type I iodothyronine deiodinase.
Sanders JP; Van der Geyten S; Kaptein E; Darras VM; Kühn ER; Leonard JL; Visser TJ
Endocrinology; 1997 Dec; 138(12):5153-60. PubMed ID: 9389495
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an iodothyronine 5'-deiodinase in gilthead seabream (Sparus auratus) that is inhibited by dithiothreitol.
Klaren PH; Haasdijk R; Metz JR; Nitsch LM; Darras VM; Van der Geyten S; Flik G
Endocrinology; 2005 Dec; 146(12):5621-30. PubMed ID: 16166227
[TBL] [Abstract][Full Text] [Related]
11. Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation.
Berry MJ; Maia AL; Kieffer JD; Harney JW; Larsen PR
Endocrinology; 1992 Oct; 131(4):1848-52. PubMed ID: 1396330
[TBL] [Abstract][Full Text] [Related]
12. Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase.
Mandel SJ; Berry MJ; Kieffer JD; Harney JW; Warne RL; Larsen PR
J Clin Endocrinol Metab; 1992 Oct; 75(4):1133-9. PubMed ID: 1400883
[TBL] [Abstract][Full Text] [Related]
13. Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast.
Kuiper GG; Klootwijk W; Visser TJ
J Mol Endocrinol; 2005 Jun; 34(3):865-78. PubMed ID: 15956354
[TBL] [Abstract][Full Text] [Related]
14. An ascidian homolog of vertebrate iodothyronine deiodinases.
Shepherdley CA; Klootwijk W; Makabe KW; Visser TJ; Kuiper GG
Endocrinology; 2004 Mar; 145(3):1255-68. PubMed ID: 14657009
[TBL] [Abstract][Full Text] [Related]
15. Rainbow trout liver expresses two iodothyronine phenolic ring deiodinase pathways with the characteristics of mammalian types I and II 5'-deiodinases.
Orozco A; Silva JE; Valverde-R C
Endocrinology; 1997 Jan; 138(1):254-8. PubMed ID: 8977411
[TBL] [Abstract][Full Text] [Related]
16. Deiodination of iodothyronine sulfamates by type I iodothyronine deiodinase of rat liver.
Rutgers M; Heusdens FA; Visser TJ
Endocrinology; 1991 Sep; 129(3):1375-81. PubMed ID: 1874177
[TBL] [Abstract][Full Text] [Related]
17. Substitution of cysteine for selenocysteine in the catalytic center of type III iodothyronine deiodinase reduces catalytic efficiency and alters substrate preference.
Kuiper GG; Klootwijk W; Visser TJ
Endocrinology; 2003 Jun; 144(6):2505-13. PubMed ID: 12746313
[TBL] [Abstract][Full Text] [Related]
18. Comparison of kidney and brown adipose tissue iodothyronine 5'-deiodinases.
Silva JE; Mellen S; Larsen PR
Endocrinology; 1987 Aug; 121(2):650-6. PubMed ID: 3595535
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recombinant Xenopus laevis type I iodothyronine deiodinase: substitution of a proline residue in the catalytic center by serine (Pro132Ser) restores sensitivity to 6-propyl-2-thiouracil.
Kuiper GG; Klootwijk W; Morvan Dubois G; Destree O; Darras VM; Van der Geyten S; Demeneix B; Visser TJ
Endocrinology; 2006 Jul; 147(7):3519-29. PubMed ID: 16601143
[TBL] [Abstract][Full Text] [Related]
20. Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system.
Campos-Barros A; Hoell T; Musa A; Sampaolo S; Stoltenburg G; Pinna G; Eravci M; Meinhold H; Baumgartner A
J Clin Endocrinol Metab; 1996 Jun; 81(6):2179-85. PubMed ID: 8964848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
